216 related articles for article (PubMed ID: 20650873)
1. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
Rech J; Ronneberger M; Englbrecht M; Finzel S; Katzenbeisser J; Manger K; Manger B; Schett G
Ann Rheum Dis; 2011 Feb; 70(2):390-2. PubMed ID: 20650873
[No Abstract] [Full Text] [Related]
2. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.
Benucci M; Li GF; Del Rosso A; Manfredi M
Clin Exp Rheumatol; 2005; 23(5):733. PubMed ID: 16173267
[No Abstract] [Full Text] [Related]
3. Prolonged efficacy of infliximab for refractory adult-onset Still's disease.
Dilhuydy MS; Vatan R; Etienne G; Longy-Boursier M; Mercié P
Clin Exp Rheumatol; 2005; 23(1):121-2. PubMed ID: 15789901
[No Abstract] [Full Text] [Related]
4. Biological treatment in adult-onset Still's disease.
Pouchot J; Arlet JB
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):477-87. PubMed ID: 23040362
[TBL] [Abstract][Full Text] [Related]
5. Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations.
Lo Gullo A; Caruso A; Pipitone N; Macchioni P; Pazzola G; Salvarani C
Joint Bone Spine; 2014 Jul; 81(4):376-7. PubMed ID: 24462130
[No Abstract] [Full Text] [Related]
6. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease.
Priori R; Ceccarelli F; Barone F; Iagnocco A; Valesini G
Clin Exp Rheumatol; 2008; 26(5):933-7. PubMed ID: 19032833
[No Abstract] [Full Text] [Related]
7. [Refractory adult-onset Still's disease].
Fain O; Rouaghe S; Stirnemann J
Rev Prat; 2010 Mar; 60(3):314. PubMed ID: 20402117
[No Abstract] [Full Text] [Related]
8. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.
Iwamoto M; Nara H; Hirata D; Minota S; Nishimoto N; Yoshizaki K
Arthritis Rheum; 2002 Dec; 46(12):3388-9. PubMed ID: 12483747
[No Abstract] [Full Text] [Related]
9. Tocilizumab for multirefractory adult-onset Still's disease.
De Bandt M; Saint-Marcoux B
Ann Rheum Dis; 2009 Jan; 68(1):153-4. PubMed ID: 19088261
[No Abstract] [Full Text] [Related]
10. [Longterm outcome of TNF blockade in adult-onset Still's disease].
Dechant C; Schauenberg P; Antoni CE; Kraetsch HG; Kalden JR; Manger B
Dtsch Med Wochenschr; 2004 Jun; 129(23):1308-12. PubMed ID: 15179590
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory adult onset Still's disease with rituximab.
Ahmadi-Simab K; Lamprecht P; Jankowiak C; Gross WL
Ann Rheum Dis; 2006 Aug; 65(8):1117-8. PubMed ID: 16837497
[No Abstract] [Full Text] [Related]
12. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).
Yoshimura M; Makiyama J; Koga T; Miyashita T; Izumi Y; Torigoshi T; Motokawa S; Eguchi K; Migita K
Clin Exp Rheumatol; 2010; 28(1):141-2. PubMed ID: 20346255
[No Abstract] [Full Text] [Related]
13. The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.
Kontzias A; Efthimiou P
Semin Arthritis Rheum; 2012 Oct; 42(2):201-5. PubMed ID: 22512815
[TBL] [Abstract][Full Text] [Related]
14. [Biological treatment of rare inflammatory rheumatic diseases].
Baslund B
Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
[TBL] [Abstract][Full Text] [Related]
15. [Anakinra in refractory adult onset Still's disease].
Vercoutere W; Starmans-Kool M; Peeters RM
Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
[TBL] [Abstract][Full Text] [Related]
16. [Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].
Sekkach Y; Elqatni M; Khattabi AE; Fatihi J; Hammi S; Badaoui M; Elomri N; Mekouar F; Amezyane T; Abouzahir A; Ghafir D
Presse Med; 2011; 40(7-8):e333-7. PubMed ID: 21550202
[TBL] [Abstract][Full Text] [Related]
17. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.
Perdan-Pirkmajer K; Praprotnik S; Tomšič M
Clin Rheumatol; 2010 Dec; 29(12):1465-7. PubMed ID: 20734215
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of a patient with refractory adult Still's disease by tacrolimus.
Murakami K; Fujii T; Yukawa N; Yoshifuji H; Kawabata D; Tanaka M; Usui T; Mimori T
Mod Rheumatol; 2007; 17(2):167-70. PubMed ID: 17437176
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis--efficacy of interleukin-6 blockade and review of the literature.
Sabnis GR; Gokhale YA; Kulkarni UP
Semin Arthritis Rheum; 2011 Feb; 40(4):365-8. PubMed ID: 20621335
[TBL] [Abstract][Full Text] [Related]
20. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.
Guignard S; Dien G; Dougados M
Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
